Hernia kia Hoti hain
hernia kya hoti hai types causes symptoms in Urdu Hindi
types of hernia diagram inguinal umbilical

Educational medical composite illustrating robotic inguinal hernia repair. Panel A is an anatomical diagram showing abdominal port placement on a male torso; it highlights a central supraumbilical port (8-12 mm) flanked laterally by two 8 mm robotic ports, essential for the da Vinci surgical system setup. Panel B displays a robotic intraoperative view of the internal inguinal region. The image shows the inguinal defect as a dark, circular opening within the reddish-pink peritoneal tissue. Distinct anatomical landmarks such as the medial umbilical ligament and the radiating striated texture of the abdominal wall are visible. Robotic surgical instruments, including a dissector and a grasping tool, are shown targeting the defect area for dissection and preparation of the preperitoneal space. This visual material demonstrates the surgical approach and anatomical orientation required for robotic-assisted transabdominal preperitoneal (rTAPP) hernia repair.

A multi-panel educational figure illustrating the key procedural steps of a Transabdominal Preperitoneal (TAPP) inguinal hernia repair. (a) Schematic diagram of the abdomen showing the laparoscopic port arrangement: a 12 mm umbilical port and two 5 mm lateral ports. (b) Intraoperative laparoscopic photograph showing the internal inguinal anatomy and the hernial orifice, classified as EHS-L2 (European Hernia Society classification for a medium indirect lateral hernia). (c) Surgical view demonstrating mesh fixation; a semi-transparent, macroporous polypropylene mesh is positioned in the preperitoneal space to cover the defect and is secured with visible surgical tacks. (d) Final procedural step showing the closure of the peritoneal flap using continuous suturing to exclude the mesh from the peritoneal cavity, preventing contact with abdominal viscera. The series emphasizes proper anatomical orientation, mesh placement, and peritoneal closure in minimally invasive hernia surgery.

This medical illustration depicts the standard trocar port placement for laparoscopic inguinal hernia repair on a male torso. The diagram uses red circular markers to indicate surgical entry points. A primary 10 mm trocar port is positioned centrally at the umbilicus. Two secondary 5 mm working ports are located bilaterally in the lower abdominal quadrants. These lateral ports are situated along the midclavicular lines, approximately 1 cm inferior to the horizontal umbilical line. This configuration is typical for providing optimal triangulation and visualization of the preperitoneal space (including Retzius and Bogros spaces) during minimally invasive abdominal surgery. The anatomical focus is on the lower abdominal wall and the geometric relationship between the umbilicus and midclavicular landmarks for surgical access.
hernia abdominal wall anatomy diagram showing defect bulge

A diagnostic image showing a coronal view of a non-contrast abdominal CT scan. The image displays the anatomy of the torso, including the liver in the right upper quadrant, the spleen in the left upper quadrant, and loops of the small and large intestines containing gas and fecal material. A yellow arrowhead points to a focal area of the left lateral abdominal wall where there is a distinct outward bulging. This area is characterized by thinning and relaxation of the abdominal wall musculature (oblique and transversus abdominis muscles). Notably, there is no evidence of a fascial defect, hernia sac, or protrusion of intra-abdominal contents into the bulge, a finding characteristic of an abdominal pseudohernia. This clinical entity is often associated with neuropathic muscle paralysis, such as that caused by herpes zoster reactivation or post-surgical nerve injury. The image serves as a clinical reference for differentiating pseudohernia from true incisional or ventral hernias based on the preservation of anatomical continuity despite muscle laxity.

This diagnostic image is a non-contrast sagittal CT scan of the abdomen and pelvis. The image clearly displays the thoracolumbar vertebral column and sacrum as posterior landmarks. The primary finding is a large ventral abdominal wall defect at the supra-umbilical level, involving the linea alba. A significant portion of solid abdominal organ tissue, consistent with liver segment III, is seen herniating through the defect into a large epigastric hernia sac. The herniated liver tissue appears homogenous with density similar to the intra-abdominal liver parenchyma, contrasting with the lower-density subcutaneous adipose tissue. There is a visible bulge on the anterior abdominal wall corresponding to the hernia sac. This clinical imaging demonstrates a complex epigastric hernia with visceral content, highlighting the potential for liver herniation in severe ventral abdominal wall defects. The image is intended for educational purposes regarding diagnostic radiology and surgical anatomy of abdominal wall hernias.
| Naam | Jagah | Khaasiyat |
|---|---|---|
| Inguinal Hernia | Groin / Kamar ke nichle hisse mein | Sabse zyada common - aant ya charbi inguinal canal mein ghus jaati hai |
| Femoral Hernia | Groin ke niche, upper thigh mein | Auraton mein zyada, strangulation ka risk zyada (40%) |
| Umbilical Hernia | Naaf (belly button) ke paas | Naaf ke paas ek ubhaar banta hai |
| Incisional Hernia | Operation ke nishaanaat (scar) ke paas | Pahle ki surgery ke baad |
| Hiatal Hernia | Pait (stomach) ka chest mein jaana | Diaphragm ki kamzori se |
| Internal Hernia | Andar ki taraf | Baahar se nazar nahi aata |
Zaroori Baat: Agar koi ubhaar nazar aaye ya dard ho, apne doctor se zaroor miley. Hernia apne aap theek nahi hoti aur waqt ke saath badh sakti hai.
What are the causes of enlargement of prostate gland
causes of prostate gland enlargement BPH pathophysiology 2024
benign prostatic hyperplasia BPH prostate anatomy zones diagram

This diagnostic axial MRI scan (T2-weighted) of the prostate illustrates severe benign prostatic hyperplasia (BPH) with transition zone hypertrophy. The transition zone is segmented with a red outline, occupying the vast majority of the prostatic volume and exhibiting a heterogeneous, predominantly medium-gray signal intensity. Due to this significant expansion, the peripheral zone is severely compressed and displaced posteriorly, visible only as a thin, crescent-shaped sliver of lower signal intensity, indicated by white arrows. This image demonstrates a common challenge in prostatic zonal segmentation and radiological assessment: the effacement of anatomical landmarks between the transition and peripheral zones. The anatomical region focuses on the mid-gland level of the prostate. Educational focus includes understanding prostatic zonal anatomy, the pathophysiological effect of transition zone expansion on surrounding tissues, and the clinical imaging characteristics of severe hypertrophy in the context of urological diagnostics and radiotherapy planning.

A comparative diagnostic MRI panel displaying axial views of the pelvic region to distinguish between Normal, Benign Prostatic Hyperplasia (BPH), and Prostate Cancer (PCa). The top row contains T1-weighted images (T1WI), while the bottom row shows T2-weighted images (T2WI). In the T1WI sequence, all three conditions present relatively homogeneous isosignals, making it difficult to differentiate the internal anatomy of the prostate. Red dashed boxes highlight regions of interest. In the T2WI sequence, significant diagnostic features are visible: the normal prostate displays a symmetrical high-signal crescent-shaped peripheral zone; BPH shows marked enlargement of the central and transitional zones while maintaining the peripheral high-signal crescent; and the PCa image demonstrates a loss of normal architecture with restricted low-signal areas in the peripheral zone and mixed signal intensity in the central region, indicative of neoplastic infiltration. These images serve as an educational comparison of signal intensity changes and morphological alterations in common prostatic pathologies.

This medical schematic illustrates the pathophysiology of benign prostatic hyperplasia (BPH) compared to a normal prostate, focusing on the molecular signaling pathways that regulate tissue growth. The diagram is divided into two comparative sections: 'Normal prostate' and 'Prostate hyperplasia.' In a normal prostate, a balanced scale shows homeostatic equilibrium between cell proliferation and cell death. Androgens, primarily dihydrotestosterone (DHT), exert agonistic effects via growth factors (KGF, EGF, IGFs) to promote proliferation, and antagonistic effects via TGF-beta to promote apoptosis. In the prostate hyperplasia model, the scale is tilted toward proliferation, indicating an 'imbalanced' state. This pathological state is characterized by increased agonistic signaling and potential hormonal shifts, where estrogens may further promote cell proliferation and inhibit cell death. The illustration uses flow arrows to define the relationships between hormonal inputs (DHT, Oestrogens), intermediary growth factors (KGF, EGF, IGFs, TGF-beta), and the resulting physiological outcomes within the prostatic stroma and epithelium.
"BPH does not occur in males who are castrated before puberty or in males with genetic diseases that block androgen activity." - Robbins & Kumar Basic Pathology

| Risk Factor | Mechanism |
|---|---|
| Age | Most important - affects ~50% of men >50 yrs, ~90% of men in their 80s |
| Androgens (DHT) | Central hormonal driver of prostate growth |
| Estrogens | With aging, testosterone falls but estrogen persists; estrogens act synergistically with DHT to further drive growth |
| Family history / Genetics | Genetic predisposition increases risk |
| Obesity / Metabolic syndrome | Increases circulating estrogens via peripheral conversion of androgens; atherosclerosis of prostatic vasculature also implicated |
| Diabetes / Insulin resistance | Higher insulin/IGF-1 levels promote prostatic cell growth |
| Sedentary lifestyle | Associated with increased BPH risk |
| Gut microbiota alterations | Emerging evidence (2024) links gut dysbiosis to prostatic inflammation |

| Cause | Zone Affected | Age Group | Key Feature |
|---|---|---|---|
| BPH | Transition zone | >50 yrs | Benign, hormonal (DHT), very common |
| Prostate Cancer | Peripheral zone | >50 yrs | Malignant, palpable on DRE, raised PSA |
| Prostatitis | Diffuse | Any age | Inflammatory, painful, usually reversible |
Management of enlargement of prostate gland
BPH management guidelines 2024 alpha blockers TURP surgical treatment
TURP transurethral resection prostate surgical procedure

A medical illustration depicting the Transurethral Resection of the Prostate (TURP) procedure. The image shows a transverse or cross-sectional view of the prostate gland housed within its surgical capsule. The left side of the gland exhibits a nodular, bumpy texture characteristic of benign prostatic hyperplasia (BPH) with multiple distinct lobules. A metallic, cylindrical surgical instrument—a resectoscope—is positioned centrally within the prostatic urethra. The resectoscope is actively removing tissue from the right side of the gland, creating a smooth, hollowed-out surgical bed as it resects tissue from the bladder neck toward the verumontanum. The anatomical focus is the lower urinary tract, specifically the prostate gland's internal architecture during a minimally invasive urological intervention. This diagram serves as a clinical education tool to demonstrate the mechanical removal of obstructive prostatic tissue to alleviate urinary symptoms.

This endoscopic intraoperative image demonstrates a Transurethral Resection of the Prostate (TURP) procedure. The primary focus is a large, white, caseous-appearing mass measuring approximately 12 mm x 15 mm x 32 mm. The mass exhibits a distinct friable, 'fluffy,' and irregular texture, characteristic of tuberculous granulomatous lesions with central caseous necrosis. It is seen protruding from the prostatic urethra into the darker, open space of the bladder lumen, causing significant urinary tract obstruction. A metallic, curved surgical loop (resectoscope loop) is visible in contact with the inferior aspect of the white mass, illustrating the active resection process. The surrounding bladder neck and prostatic urethral tissue appear hyperemic with a brownish-red, rough surface texture, contrasting sharply with the pale necrotic material. This clinical photograph is used to teach the visual presentation of genitourinary tuberculosis as a cause of bladder outlet obstruction and its differentiation from typical benign prostatic hyperplasia or prostatic malignancy during endoscopy.
| Drug | Dose | Type |
|---|---|---|
| Tamsulosin | 0.4-0.8 mg daily | α1A-selective (prostate-specific) |
| Silodosin | 8 mg daily | α1A-selective |
| Alfuzosin | 10 mg daily | α1A-selective |
| Terazosin | 5-10 mg daily | α1, long-acting |
| Doxazosin | 4-8 mg daily | α1, long-acting |
| Drug | Dose | Isoenzyme blocked |
|---|---|---|
| Finasteride | 5 mg daily | Type 2 only |
| Dutasteride | 0.5 mg daily | Type 1 and 2 (more potent) |


| Procedure | Description |
|---|---|
| HoLEP (Holmium Laser Enucleation) | Laser enucleates prostatic lobes; effective for large glands |
| GreenLight PVP (Photoselective Vaporization) | Laser vaporizes tissue; less bleeding |
| TUIP (Transurethral Incision) | Incisions in bladder neck; for small glands |
| Rezum (Water Vapor Therapy) | Steam injected into transition zone causes necrosis; day procedure; preserves ejaculation |
| UroLift (Prostatic Urethral Lift) | Implants hold lateral lobes apart; no cutting or heat; preserves sexual function |
| Robotic Waterjet (Aquablation) | Robotic water jet ablation; retreatment rate <5% at 5 years; preserves ejaculatory function better than TURP |
| Complication | Management |
|---|---|
| Acute Urinary Retention | Urinary catheterization (Foley), then trial without catheter (TWOC) with alpha-blocker; TURP if fails |
| Recurrent UTI | Treat infection, then definitive surgical relief of obstruction |
| Renal failure (hydronephrosis) | Urgent catheterization, nephrology consult |
| Bladder stones | Cystolithotripsy + TURP |
BPH Diagnosed
|
IPSS Score
|
┌───┴───┐
Mild Moderate/Severe
(0-7) (8-35)
| |
Watchful Medical Therapy
Waiting (Alpha-blocker ± 5α-RI)
|
Not improving /
Complications
|
SURGICAL (TURP / MIST)
Ye medicine de hain doctor ny
Citralka syrup uses urinary alkalinizer sodium citrate potassium citrate
| Dawai | Maqsad |
|---|---|
| Ciprofloxacin | Bacterial infection khatam karna |
| Etoricoxib | Dard aur sojan kam karna |
| Citralka | Peshab ki jalan kam karna + antibiotic ka asar badhana |
⚠️ Zaroori: Dawai poori miqdar mein aur poore waqt ke liye lein. Agar 3 din mein aaraam na aaye, jwar (bukhaar) aa jaaye, kamar mein dard ho ya peshab mein khoon aaye to foran doctor ko dobara dikhayein - yeh kidney infection ki alamat ho sakti hai.
Aur report ye hai
| Measurement | Report ki Reading | Normal Hona Chahiye |
|---|---|---|
| Size | 3.1 cm × 5.3 cm × 3.8 cm | ~3 cm × 4 cm × 3 cm |
| Volume | 33 ml | 20-30 ml |
| Weight | 34 grams | 20 grams tak (upper limit) |
| Capsule | Intact (salaamat) | Intact honi chahiye |
| Hypoechoic area | Nahi mili | Nahi honi chahiye (cancer ka sign hota) |
| Calcification | Nahi | -- |
✅ Matlab: Prostate badi ho gayi hai - weight normal ki had se 14 gram zyada hai. Lekin capsule salaamat hai aur cancer ka koi nishaan nahi - yeh BPH (Benign Prostatic Hyperplasia) hai yani ek non-cancerous enlargement.
| Finding | Report | Matlab |
|---|---|---|
| Bladder wall | Thodi moti (slightly thick) | Sojan ki wajah se |
| Mass ya pathri | Nahi | Good - koi serious masla nahi |
| Pre-micturation volume | 507 ml | Peshab karne se pehle masane mein itna pani tha |
| Post-micturation volume | 73 ml (residual urine) | Peshab karne ke baad bhi 73ml reh gayi |
⚠️ Residual Urine 73ml: Yeh thoda zyada hai. Normal mein peshab ke baad masana bilkul khali ho jaata hai (< 50ml). Iska matlab prostate ki wajah se peshab poori tarah nahi nikal rahi - yeh bladder outlet obstruction ki alamat hai.
⚠️ Thick Bladder Wall: Yeh Mild Cystitis (masane ki sojan/infection) ki taraf ishara karta hai - isliye doctor ne antibiotic (Ciprofloxacin) di hai.
Bilateral early reducible indirect inguinal hernia
- Dono taraf (right aur left) inguinal hernia hai
- Right side: 7.4mm, Left side: 8.7mm
- "Early reducible" matlab: abhi choti hai aur wapas ja sakti hai - fouri surgery ki zaroorat nahi lekin nazar rakhen
- Hum ne pehle baat ki thi hernia ke baare mein - yeh wahi hai!
Penile shaft soft tissue edema
- Ling ke hisse mein thodi sojan hai
- Yeh UTI/infection ya local inflammation ki wajah se ho sakta hai
| # | Finding | Matlab |
|---|---|---|
| 1 | Prostate enlarged 34g (normal 20g) | BPH - Benign Prostatic Hyperplasia |
| 2 | Bladder residual urine 73ml | Prostate ki wajah se peshab poori nahi nikal rahi |
| 3 | Thick bladder wall | Mild Cystitis (masane ki infection/sojan) |
| 4 | Bilateral inguinal hernia | Ittifaqan mili - future mein surgical consultation |
| Dawai | Kyun Di |
|---|---|
| Ciprofloxacin | Cystitis (masane ki infection) khatam karne ke liye |
| Etoricoxib | Dard aur sojan (masana + prostate) kam karne ke liye |
| Citralka | Peshab ki jalan kam karo + urine alkaline karo |
🔔 Aham Baat: Yeh dawaiyen sirf UTI aur infection ka ilaj karengi. Prostate ki BPH ki wajah se jo peshab poori nahi nikal rahi - us ke liye doctor agle visit mein shayad Alpha-blocker (Tamsulosin) ya koi aur BPH ki dawai bhi shuru karen. Ashraf sahab ko follow-up zaroor karwaani chahiye.
Tamsulosin bh chl rahi hai
Lippincott Pharmacology ke mutabiq: "Tamsulosin and silodosin are more selective for the α1A receptor found in the prostate - they have less effect on blood pressure because they target prostate-specific receptors."
| Masla | Tamsulosin ka Faida |
|---|---|
| Peshab poori tarah nahi nikal raha | Prostate relax → peshab poora nikal jayega |
| Residual urine 73ml | Kam hogi - target < 50ml |
| Peshab ki dhaar kamzor | Flow rate behtar hogi |
| Baar baar peshab ki hajat | Urgency aur frequency kam hogi |
| Raat ko uthna (Nocturia) | Behtar neend |
| Side Effect | Kitna Common | Kya Karein |
|---|---|---|
| Chakkar aana (dizziness) | Thoda | Dhire se uthein, seedha na kharen |
| Blood pressure thoda gire | Kam (kyunki α1A selective hai) | Pareshani nahi |
| Retrograde ejaculation | Ho sakta hai | Mani peeche masane mein jaati hai - nuqsandeh nahi |
| Naak band rehna | Kabhi kabhi | -- |
| Floppy Iris Syndrome | Aankh ki surgery mein | ⚠️ Agar cataract ki surgery honi ho to doctor ko zaroor batayein ke Tamsulosin chal rahi hai |
| Dawai | Kaam | Timing |
|---|---|---|
| Ciprofloxacin 250mg | UTI/Cystitis infection khatam kare | Subah + Raat (khaane ke baad) |
| Etoricoxib 60mg | Dard + sojan kam kare | Subah ek baar (khaane ke baad) |
| Citralka Syrup | Peshab ki jalan kam kare | Subah + Raat (paani mein mila kar) |
| Tamsulosin 0.4mg | Prostate relax kare, peshab aasaan kare | Raat ko sone se pehle (khaane ke baad) |
✅ Khulasa: Doctor ne bilkul sahi treatment di hai - infection ke liye antibiotic, dard ke liye pain killer, jalan ke liye Citralka, aur BPH ke liye Tamsulosin. Yeh ek complete package hai. Tamsulosin lifelong bhi chal sakti hai - apni marzi se band na karein.